155P PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy
| Title: | 155P PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy |
|---|---|
| Authors: | Do, S.K., Lee, S.Y., Choi, J.E., Hong, M.J., Lee, J.H., Park, J.Y. |
| Source: | In Journal of Thoracic Oncology April 2016 11(4) Supplement:S125-S125 |
| Database: | ScienceDirect |
| ISSN: | 15560864 |
|---|---|
| DOI: | 10.1016/S1556-0864(16)30265-9 |
| Published in: | Journal of Thoracic Oncology |
| Language: | English |